Innoviva Inc. Stock
Price
Target price
€14.20
€14.20
2.140%
0.3
2.140%
€30.00
23.04.24 / Tradegate
WKN: A2AC9U / Symbol: INVA / Name: Innoviva / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Innoviva Inc. Stock
There is an upward development for Innoviva Inc. compared to yesterday, with an increase of €0.30 (2.140%).
Currently there is a rather positive sentiment for Innoviva Inc. with 3 Buy predictions and 0 Sell predictions.
With a target price of 30 € there is potential for a 111.27% increase which would mean more than doubling the current price of 14.2 € for Innoviva Inc..
Pros and Cons of Innoviva Inc. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
S********** s********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Innoviva Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Innoviva Inc. | 2.140% | 2.899% | 2.899% | 30.275% | -2.740% | 46.392% | - |
| Avid Bioservices Inc | - | -1.563% | 1.613% | -64.804% | 3.279% | -64.000% | 54.753% |
| Rockwell Medical Inc. | 1.620% | -4.810% | -3.193% | -26.923% | -20.034% | -85.152% | -96.854% |
| Gritstone Oncology Inc | -5.040% | 9.065% | -69.921% | -67.350% | -58.881% | -89.974% | - |
Comments
Innoviva, Inc. (NASDAQ: INVA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for INVA provided by MarketBeat
Innoviva, Inc. (NASDAQ: INVA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for INVA provided by MarketBeat
Innoviva, Inc. (NASDAQ: INVA) had its "buy" rating re-affirmed by analysts at EF Hutton Acquisition Co. I. They now have a $22.50 price target on the stock.
Show more
Ratings data for INVA provided by MarketBeat
